Invest In Biomed

Arnaud Debains and Sandrine Isz (BOYDSense): "Invest In Biomed helped us tell our story better".

Arnaud Debains and Sandrine Isz (BOYDSense): "Invest In Biomed helped us tell our story better".

March 31, 2025
Arnaud Debains and Sandrine Isz are respectively Chief Financial Officer and Chief Science Officer of BOYDSense, a young company developing an innovative respiratory analysis technology, enabling patients to easily track their state of health and monitor their chronic pathologies, notably diabetes. Winner of Eurobiomed's Invest In Biomed program in 2023, BOYDSense raised a round of financing in April 2024.
Read more
No results found.